April 26, 2023 | Office of the President & Chief Research Officer

Stanley Manne Children’s Research Institute
President’s Message

Dear Teammates,


The spirit of collaboration is a key to pediatric biomedical research discoveries and can carry us on journeys across scientific and technological boundaries, where we can be inspired and informed by experts in engineering and related fields. We created Manne Research Institute’s Engineered Solutions for Health neighborhood, which resides in our Basic and Preclinical Science pillar, to encourage the combined use of biomedical and engineering approaches to solve pediatric health challenges. Empowering these cross-disciplinary collaborations is our research partnership with and physical proximity to Northwestern University, a dynamic that fosters investigation of biological systems in pursuit of breakthrough therapies and technologies. A partnership that has excelled in this environment is between Arun Sharma, PhD, Director of Pediatric Urological Regenerative Medicine at Lurie Children’s, and Samuel Stupp, PhD, Director of the Simpson Querrey Institute for BioNanotechnology and Board of Trustees Professor of Materials Science and Engineering, Chemistry, Medicine, and Biomedical Engineering at Northwestern University. Together, they are breaking ground in the use of nanotechnology to find non-permanent, biodegradable solutions to inflammation.

Through his pioneering work on self-assembling organic materials, Sam has created nanoscale fibers embedded with molecules that can signal cells involved in tissue regeneration. They’re designed to mimic the fibers that exist naturally in the extracellular matrices where cells receive signals to express specific genes or instructions to either grow or not grow. While Sam has demonstrated that these nanoscale structures play key roles in bone, cartilage, muscle, and spinal cord regeneration, he has also discovered their potential to target inflammation associated with injuries in tissues or surgical interventions.

Mark Seniw at the Simpson Querrey Institute Northwestern University

Highly specialized nanofibers (grey, purple, and green) provide a novel treatment option for inflamed intestinal tissue (white and pink) observed in inflammatory bowel diseases. These nanofibers can be engineered to deliver potent anti-inflammatory molecules that are highly reproducible, non-toxic, and biodegradable and can be administered repeatedly via venous injection.


This image was selected as the cover art for the October 2022 issue of the journal Advanced Biology.


Image Credit: Mark Seniw, Simpson Querrey Institute, Northwestern University 

This discovery has proved important to Arun and his lab, who have had a long-standing collaboration with Sam and his team. While Sam's lab developed the nanofibers, Arun's team engineered their anti-inflammatory components. Originally, they refined the design of the nanofibers to target inflammation associated with bladder regeneration. Now, they are finalizing research to demonstrate next-generation nanofibers constructed with both a homing mechanism and anti-inflammatory components that can travel directly to the intestine and combat inflammation associated with Crohn’s disease—a research focus Arun credits as being inspired by a discussion between him and his team member about her relative with the disease. Moreover, these new applications open additional doors to scalable therapeutics and potential investments. 


The collaboration between Sam and Arun illustrates the role interdisciplinary research plays in taking discoveries in the lab and evolving them into novel therapies. Within our Engineered Solutions for Health neighborhood, we’ve seen how combining the expertise of biomedical researchers and engineers has led to solutions in the surgical operating suite, and to medical devices specifically designed for infants. Cross-disciplinary partnerships illuminate new pathways to the therapies and technologies we need to serve the pediatric patient population, and I’m looking forward to celebrating more of these achievements.


With kindness and respect,

Pat

Patrick C. Seed, MD, PhD, FAAP, FIDSA
President & Chief Research Officer
Stanley Manne Children’s Research Institute
Children's Research Fund Chair in Basic Science
Director, Host - Microbial Interactions, Inflammation, and Immunity (HMI3) Program
Professor of Pediatrics, Microbiology & Immunology
Northwestern University Feinberg School of Medicine
Ann & Robert H. Lurie Children’s Hospital of Chicago
LinkedIn Share This Email
Lurie Children's logo
Twitter  Linkedin